Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Effects of Hyperventilation, Post-Activation Performance Enhancement, and Combined Protocols on Anaerobic Capacity and Energy System Contributions

NCT07903714 is registered in ClinicalTrials.gov with Manisa Celal Bayar University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07903714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Effects of Hyperventilation, Post-Activation Performance Enhancement, and Combined Protocols on Anaerobic Capacity and Energy System Contributions
Lead sponsor
Manisa Celal Bayar University
Phase
Not applicable
Overall status
Completed
Start date
February 11, 2026
Completion date
February 26, 2026
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaerobic performance, energy system contributions, hyperventilation, post activation potentiation

Arms

As registered; 4 arms.

  • Control Session Active comparatorWingate Anaerobic Test

    Baseline 30-s Wingate test without prior intervention.

  • Hyperventilation (HV) Session ExperimentalVoluntary Hyperventilation, Wingate Anaerobic Test

    30-s Wingate test preceded by voluntary hyperventilation.

  • PAPE Session ExperimentalPost-Activation Performance Enhancement (PAPE), Wingate Anaerobic Test

    30-s Wingate test preceded by PAPE protocol.

  • PAPE+HV Session ExperimentalPost-Activation Performance Enhancement (PAPE), Voluntary Hyperventilation, Wingate Anaerobic Test

    30-s Wingate test preceded by combined PAPE and hyperventilation protocols.

Primary endpoints

Registered primary outcome measures; 3 primary.

  • Relative Peak Power (RPP) During the 30-second Wingate anaerobic test

    Evaluation of relative peak power during the 30-second Wingate anaerobic test

  • Relative Mean Power (RMP) During the 30-second Wingate anaerobic test

    Evaluation of relative mean power during the 30-second Wingate anaerobic test.

  • Fatigue Index (FI) During the 30-second Wingate anaerobic test

    Evaluation of fatigue index during the 30-second Wingate anaerobic test.

Lead sponsor's other trials

Manisa Celal Bayar University, most recent start first.

Similar trials

Same condition (Hyperventilation) and phase, most recent start first.